Format

Send to

Choose Destination
J Nucl Cardiol. 2019 Feb 20. doi: 10.1007/s12350-019-01655-6. [Epub ahead of print]

Nuclear cardio-oncology: From its foundation to its future.

Author information

1
Cardiovascular Division and the Cardiovascular Imaging Center, Department of Medicine, University of Virginia Health System, Box 800158, 1215 Lee Street, Charlottesville, VA, 22908, USA.
2
Cardiovascular Division and the Cardiovascular Imaging Center, Department of Medicine, University of Virginia Health System, Box 800158, 1215 Lee Street, Charlottesville, VA, 22908, USA. jbourque@virginia.edu.
3
Department of Radiology, University of Virginia Health System, Charlottesville, VA, USA. jbourque@virginia.edu.

Abstract

Cardio-oncology is a growing field focused on the prevention and treatment of cardiovascular disease in oncologic patients. While a major focus of chemotherapy-related cardiac dysfunction has been on left ventricular ejection fraction, oncologic treatment can lead to cardiovascular pathology in a variety of ways. The use of multimodality imaging is essential to the care of these patients, with nuclear cardiology playing an important role. We will review nuclear cardiology's history, its current role, and its promising future in cardio-oncology and the management of these patients.

KEYWORDS:

Cardiomyopathy; Diagnostic and prognostic application; Metabolic; Molecular imaging agents; Multimodality

PMID:
30788760
DOI:
10.1007/s12350-019-01655-6

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center